Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2 USD | +6.95% | +5.82% | +0.50% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.50% | 34.71M | |
+16.49% | 82.59B | |
-29.52% | 69.86B | |
0.00% | 26.5B | |
-13.29% | 16.61B | |
+1.00% | 17.29B | |
+1.57% | 15.56B | |
+71.63% | 13.2B | |
+1.53% | 12.75B | |
+70.68% | 12.6B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- BTIG Adjusts Price Target on Exagen to $5 From $6, Maintains Buy Rating